Lengthy study start-up timelines cost sites and sponsors time and money and may prevent would-be participants from receiving potentially life-saving treatments. This session considers how study start-up sets the stage for trial conduct into the enrollment, maintenance, and close-out phases, so reducing errors and miscommunication during start-up fosters success during the other phases of the trial. Both sponsors and sites alike can take steps to expedite the start-up process using best practices that can enhance the overall conduct of the trial.

CEU: 1.00 ACRP

Speaker:

Jessica Propps, Clinical Operations Manager - Regulatory, Merck

Watch a Sneak Peek into the Session Content: